seven female patients with classical rheumatoid arthritis ( ra ) , treated successfully with injectable gold salts ( fosfocrisolo ici , 0.10 g/week , with a serum gold concentration of 200-400 mcg/dl ) , experienced severe gold side-effects after 3 to 20 months of therapy , requiring their withdrawal from gold despite the good results in both clinical and laboratory findings .
C0003873
rheumatoid arthritis
C0018026
gold